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Abstract  A  worldwide  rise  in  weight  and  obesity  is  taking  place,  associated  with  an  increase
in several  comorbid  conditions,  such  as  Obstructive  Sleep  Apnea  (OSA).  Bariatric  surgery  is
an effective  treatment  approach  for  obesity,  with  resultant  improvement  in  obesity-related
comorbidities.  However,  the  relationship  between  this  type  of  treatment  and  OSA  is  not  well
established.  This  systematic  review  aims  to  assess  and  characterize  the  impact  that  different
types of  bariatric  surgery  have  on  obese  OSA  patients.  22  articles  with  stated  preoperative
apnea--hypopnea  index  (AHI),  apnea  index  (AI)  or  respiratory  disturbance  index  (RDI)  were  ana-
lyzed in  this  review.  A  signiﬁcant  improvement  in  AHI/AI/RDI  occurred  after  surgery,  in  addition
to the  foreseeable  reduction  in  body  mass  index  (BMI).  Moreover,  almost  every  study  stated  a
postoperative  reduction  of  the  AHI  to  <  20/h  and/or  a  >50%  postoperative  reduction  of  AHI,  with
few exceptions.  The  interventions  with  a  combined  malabsorptive  and  restrictive  mechanism,
like roux-en-Y  gastric  bypass  (RYGB),  were  more  efﬁcacious  in  resolving  and  improving  OSA  than
purely restrictive  ones,  like  laparoscopic  adjustable  gastric  banding  (LAGB).
In conclusion,  bariatric  surgery  has  a  signiﬁcant  effect  on  OSA,  leading  to  its  resolution  or
improvement,  in  the  majority  of  cases,  at  least  in  the  short/medium  term  (1--2  years).  How-
ever, the  different  results  must  be  interpreted  with  caution  as  there  are  many  potential  biases
resulting from  heterogeneous  inclusion  criteria,  duration  of  follow-up,  diagnostic  methodology
and assessed  variables.
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BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)ntroductionlobally,  increased  weight  and  obesity  are  rising  in  both  the
eveloping  and  developed  world.1 Data  from  the  National
ealth  and  Nutrition  Examination  Surveys  (NHANES)  col-
ected  between  2011  and  2012  suggest  that  35%  of  adults
Elsevier Espan˜a, S.L.U. This is an open access article under the CC
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success  of  surgery  was  deﬁned  as  a  postoperative  reduc-32  
re  obese,2 and  the  rates  of  this  disease  throughout  the
orld  have  increased  dramatically  over  the  past  40  years
nd  continue  to  rise  in  many  countries.3 Compared  with
ormal-weight  people,  obese  individuals  are  responsible  for
6%  higher  inpatient  costs,  27%  more  outpatient  visits,  and
0%  higher  spending  on  prescription  medications.2
Obesity  is  a  complex,  multifactorial  disease  that  is
trongly  associated  with  multiple  comorbidities,  such  as
ertain  types  of  cancer,  cardiovascular  disease,  disabil-
ty,  diabetes  mellitus,  gallbladder  disease,  hypertension,
steoarthritis,  sleep  apnea  and  stroke.2
Body  mass  index  (BMI)  has  been  one  of  the  most  widely
sed  measures  for  determining  the  prevalence  of  obesity,
ue  to  its  accuracy  in  the  assessment  of  body  composition,
ith  a  high  correlation  with  body  fat  percentage.4 Obesity
s  classiﬁed  as  a  BMI  ≥30  kg/m2,  with  subsequent  sub-
lassiﬁcation  as  follows:  severe  obesity  (BMI  ≥35  kg/m2),
orbid  obesity  (BMI  ≥40  kg/m2),  and  super  obesity  (BMI
50  kg/m2).4 Bariatric  (weight  loss)  surgery  is  generally  con-
idered  for  patients  with  a  BMI  ≥40  kg/m2 or  for  those  with  a
MI  ≥35  kg/m2 with  at  least  1  serious  weight-related  comor-
id  condition,  such  as  type  2  diabetes,  Obstructive  Sleep
pnea  (OSA),  or  disabling  joint  disease.3 Laparoscopic  gas-
ric  banding  is  also  FDA-approved  for  patients  with  a  BMI
30  kg/m2 and  type  2  diabetes.3 Before  having  surgery,
atients  should  have  made  sustained  attempts  at  weight  loss
ith  lifestyle  modiﬁcation  and/or  pharmacotherapy.  It  is
urrently  standard  of  care  for  patients  considering  bariatric
urgery  to  undergo  preoperative  psychological  evaluation  to
etermine  whether  surgery  is  appropriate,  and  they  must
lso  be  informed  of  the  potential  risks  of  surgery  and  the
eed  for  long-term  monitoring  of  their  weight  and  nutri-
ional  status.3
The  diagnosis  of  OSA  is  conﬁrmed  if  the  number  of
bstructive  events  on  a  polysomnographic  study  (apneas,
ypopneas  +  respiratory  event  related  arousals)  is  greater
han  15  events/h  or  greater  than  5/h  in  a  patient  who
eports  any  of  the  following:  unintentional  sleep  episodes
uring  wakefulness;  daytime  sleepiness;  unrefreshing  sleep;
atigue;  insomnia;  waking  up  holding  their  breath;  gasp-
ng,  or  choking;  or  the  bed  partner  describing  loud  snoring,
reathing  interruptions,  or  both  during  the  patient’s  sleep.5
he  frequency  of  obstructive  events  is  reported  as  an
pnea--hypopnea  index  (AHI)  or  respiratory  disturbance
ndex  (RDI),5 the  main  difference  being  the  fact  that  the
atter  also  takes  into  account  the  respiratory  event  related
rousals.  OSA  severity  is  deﬁned  as  mild  for  AHI  or  RDI  ≥5
nd  <15,  moderate  for  AHI  or  RDI  ≥15  and  ≤30,  and  severe
or  AHI  or  RDI  >30/h.5
Obesity  is  the  most  signiﬁcant  predisposing  factor  for
SA.6,7 An  elevation  of  6  kg/m2 in  BMI  leads  to  a  four  times
reater  risk  of  developing  OSA.7 Central  obesity,  character-
zed  by  fat  distribution  at  the  abdominal  level,  upper  body
nd  neck,  is  the  one  most  associated  with  OSA.7 Moreover,
hen  compared  with  normal  individuals,  obese  patients  with
SA  have  42%  more  fat  in  their  neck,  resulting  in  pharyn-
eal  lumen  narrowing  and  higher  risk  of  OSA  development.8
nother  possible  pathophysiological  mechanism  that  may
xplain  OSA  development  in  obese  patients  involves  the  hor-
ones  produced  by  adipocytes,  such  as  Leptin,  whose  levels
re  known  to  be  correlated  with  human  obesity,  in  a  condi-
ion  known  as  Leptin  resistance.7 This  hormone  not  only
t
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as  a  key  role  on  body-weight  control,  but  also  on  respi-
atory  center  control.9 Thus,  increased  Leptin  levels  in  a
eptin  resistance  environment  are  possibly  involved  in  the
athophysiology  of  sleep  disorders.9,10
In  reviewing  the  literature,  this  work  aims  to  assess  and
haracterize  the  impact  that  different  types  of  bariatric
urgery  have  on  obese  OSA  patients,  using  AHI/AI(apnea
ndex)/RDI  variation.
ethods
 comprehensive  search  in  the  ‘‘Natural  Library  of  Medicine
UBMed  -- Medline’’  was  conducted,  using  the  search  terms:
bariatric  surgery  OR  obesity  surgery)  AND  sleep  apnea,
n  title  or  abstract.  The  inclusion  criteria  were:  studies
hat  speciﬁcally  assessed  the  relationship  between  bariatric
urgery  and  sleep  apnea  and  availability  of  information
egarding  AHI/AI/RDI  variation  with  surgery.  The  exclu-
ion  criteria  were:  studies  in  a  non  English  language,
ot  conducted  in  humans  and  with  unstated  preoperative
HI/AI/RDI.
elected  articles
032  articles  were  retrieved  from  the  initial  search,  of  which
89  were  rejected  after  reading  the  title  and  abstract,  as
hey  met  exclusion  criteria.  From  the  remaining  43  articles,
1  were  also  rejected  as  they  did  not  meet  the  inclu-
ion  criteria.  Therefore,  22  articles  were  analyzed  in  this
eview.11--32
esults
able  1  is  structured  in  order  to  systematically  assess  the
ffect  of  bariatric  surgery  on  the  severity  of  sleep  apnea
ased  on  the  different  studies  analyzed  with  stated  pre-
perative  AHI/AI/RDI.  Moreover,  the  following  information
as  also  collected  and  organized:  time  of  follow-up;  loss
o  follow-up;  BMI  and  AHI/AI/RDI  variation;  AHI/AI/RDI
eduction  after  surgery;  study  design;  and  type  of  sleep
uestionnaire  used  for  symptoms  evaluation.
Average  AHI/AI/RDI  reduction  was  calculated  for  each
ariatric  procedure  using  the  available  data  from  the  dif-
erent  studies  (Fig.  1).
iscussion
s  previously  stated,3 bariatric  surgery  not  only  provides  sig-
iﬁcant,  fast  and  sustained  weight  loss,  as  it  also  provides
ptimal  outcomes  in  the  reduction  of  frequently  associ-
ted  co-morbidities,  such  as  OSA.  The  impact  of  weight
oss  after  bariatric  surgery  on  obese  patients  with  OSA  has
een  assessed  through  several  questionnaires  which  aim
o  characterize  symptoms  and  variations  in  pressure  lev-
ls  used  in  Continuous  Positive  Airway  Pressure  (CPAP),  and
lso  OSA  severity  changes  as  seen  on  polysomnography.  Theion  of  the  AHI  to  <20/h  and  >50%  reduction,  in  patients
hose  preoperative  AHI  was  >20/h.33 Other  authors  later
roposed  tightening  these  criteria  to  a  postoperative  AHI  <15
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Table  1  Effect  of  bariatric  surgery  on  the  severity  of  Obstructive  sleep  apnea.
Study  N  Type  of  surgery Follow-up
(months)
Loss  to
follow-up  (%)
BMI  AHI/AI/RDI  AHI/AI/RDI
reduction  (%)
Study
design
Questionnaire
Before  After  Before  After
Aguiar28 16  LAGB  3  0  48.15 36.91 15.65 6.26 60  RCT  ESS  +  BQ
Bae29 47  RYGB 13.9 79  39.9 26.9 51  9.3 82  P  ESS  +  PSQI
Busetto11 18  IB  6  6  55.8 48.6 59.3 14  76  P  ESS
Del Genio30 36  SG  60  0  51.3 32.1 32.8 5.8 82  P  ESS
Dixon12 26  LAGB  24  20  46.3 36.6 65  39.5 39  RCT  ESS
Feigel-Guiller31 30  LAGB  12  13  48.8 41.5 56.5 31.5 44  RCT ††
Feigel-Guiller31 30  LAGB  36  27  48.8 42.2 56.5 40.7 28  RCT ††
Fritscher13 18  RYGB 24.2 33  51.5 34.1 46.5 16  66  P  ESS
Guardiano14 34  RYGB 28  76  49  34  55** 14** 75  R  --
Haines15 289  RYGB 11  65  56  38  51** 15** 71  P  ESS
Kalra16 19  RYGB 5.1 47  60.8 41.6 9.1 0.65 93  R  --
Lettieri17 25  LAGB  12  4  51.0 32.1 47.9 24.5 49  P  ESS
Marti-Valeri18 14  RYGB 12  0  56.5 32.1 63.6** 17.5** 72  P  --
Peiser19 15  RYGB 3  0  142* 106* 82*** 15*** 82  P  TSQ
Peiser19 15  RYGB  6  60  142* 97* 82*** 5.5*** 93  P  TSQ
Pillar20 14  RYGB  and  VBG  4.5  0  45  33  40*** 11*** 73  P  --
Pillar20 14  RYGB  and  VBG  90  0  45  35  40*** 24*** 40  P  --
Poitou21 35  RYGB  and  LAGB 12.7 0  51.3  39.9  24.5  9.7  60  P ††
Rao22 228  LAGB  12.6 80† 45.2  30  38.11  13.18  65  PR  ESS
Rasheid23 87  GBP  21  87  62  40  56** 23** 59  P  ESS
Ravesloot24 171  LAGB,  GBP  and  SG 7.7 36  45.4  36.3  39.5  15.6  61  P  ESS
Ravesloot24 171  LAGB,  GBP  and  SG 16.9 71  45  35  49.1  17.4  65  P  ESS
Scheuller25 15  GBP  and  VBG 12--144  0  160* 105* 96.9** 11.3** 88  P  --
Sugerman26 110  GBP  and  HG 12  43  56  37  64  33  48  P  --
Sugerman26 110  GBP  and  HG 54  48  56  38  64  32  50  P  --
Valencia-Flores27 28  RYGB  and  VBG 13.7  0  54.9  39.2  71.9  27.1  62  P  --
Zou32 54  RYGB 9.7  19  31.1  24.4  22.4  7.1  68  P  ESS
GBP -- gastric bypass; VBG -- vertical gastroplasty with band or ring; HG -- gastroplasty; IB -- intragastric balloon; LAGB -- laparoscopic adjustable gastric banding; RYGB -- roux-en-Y gastric
bypass; SG -- sleeve gastrectomy; BMI -- body mass index (kg/m2); AHI -- apnea--hypopnea index; ESS -- Epworth Sleeping Scale; BQ -- Berlin Questionnaire; PSQI -- Pittsburgh Sleep Quality
Index; TSQ -- Technion Sleep Questionnaire; P -- prospective non randomized (case series); RCT -- randomized controlled trial; R -- retrospective; PR -- prospective randomized.
* Weight in kilograms.
** Respiratory disturbance index.
*** Apnea index.
† A limited number of patients were randomly selected to be evaluated postoperatively.
†† Used a non speciﬁed questionnaire; All studies showed statistically signiﬁcant associations (p < 0.05), except the Scheuller et al.25 study; The majority of studies used full type 1
Polysomnography, except the Busetto et al.11 and the Poitou et al.11 that used cardiorespiratory sleep studies. The Ravesloot et al.11 study used type 1 and type 2 Polysomnography and
the Sugerman et al.11 study used type 1 Polysomnography and sleep capneography; N represents the total number of patients with OSA in the beginning of the study, who underwent a
bariatric procedure.
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Figure  1  Percentage  of  AHI/AI/RDI  reduction  in  each  type
of bariatric  procedure  during  the  following  average  follow-up
periods:  IB  --  intragastric  balloon  (6  months);  Several  --  more
than one  procedure  (52  ±  39  months);  LAGB  --  laparoscopic
adjustable  gastric  banding  (17  ±  13  months);  RYGB  --  roux-en-
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i gastric  bypass  (12  ±  10  months);  SG  --  sleeve  gastrectomy  (60
onths);  GBP  --  gastric  bypass  (21  months).
regarded  as  ‘‘clinically  relevant’’  OSA),  <10,  and  recently
ven  <5.34 One  study  has  considered  ‘‘response  rate’’  as  a
eduction  of  the  AHI  between  20%  and  50%,35 and  another
tudy36 has  stated  that  a  goal  of  a  mean  AHI  ≤5,  for  both
urgery  and  CPAP  therapy,  is  rarely  achievable.  Therefore,
he  ﬁrst  mentioned  criteria  were  considered  in  the  present
eview.
In  almost  all  studies  in  Table  1,  a  statistically  signiﬁcant
mprovement  in  AHI  occurred  after  surgery,  in  addition  to
he  foreseeable  reduction  in  BMI,  with  the  exception  of  the
cheuller  et  al.  study,25 that  did  not  include  a  ‘p’  value.
owever,  there  was  a  reduction  in  both  AHI  and  BMI  after
urgery.  Almost  every  study  from  this  table  was  conducted
n  patients  with  a  preoperative  AHI  >20/h,  with  the  excep-
ion  of  the  Aguiar  et  al.28 and  the  Kalra  et  al.16 studies.
n  the  latter,  this  ﬁnding  may  be  explained  by  the  fact  that
ubjects  from  this  study  were  adolescents  with  milder  forms
f  the  disease.  In  the  former,  the  fact  that  the  majority  of
atients  were  women  may  justify  the  lower  mean  AHI  of  the
roup.  Almost  every  study  from  this  table  stated  a  postop-
rative  reduction  of  the  AHI  to  <20/h,  the  exceptions  being
he  Dixon  et  al.,12 Feigel-Guiller  et  al.,31 Lettieri  et  al.,17
illar  et  al.,20 Rasheid  et  al.23 and  Sugerman  et  al.26 stud-
es.  The  >50%  postoperative  reduction  of  AHI  was  achieved
n  almost  all  studies  in  Table  1,  with  the  exceptions  of  the
ixon  et  al.,12 Feigel-Guiller  et  al.,31 Lettieri  et  al.,17 Suger-
an  et  al.26 (50%  reduction)  and  Pillar  et  al.20 studies.  In  the
atter,  a  signiﬁcant  decrease  in  AHI  from  40/h  to  11/h  was
bserved  at  4.5  months,  followed  by  a  twofold  increase  to
4/h  at  7.5  years,  this  alteration  being  independent  of  BMI
ariation.  Likewise,  in  the  Feigel-Guiller  et  al.31 study  a  sig-
iﬁcant  decrease  in  AHI  from  56.5/h  to  31.5/h  was  observed
t  12  months,  followed  by  an  increase  to  40.7/h  at  3  years.
s  a  previous  systematic  review37 stated  this  may  be  due  to
he  fact  that  OSA  possibly  relapses  in  the  years  following
urgery,  probably  attributable  to  causes  other  than  simply
eight  gain.  Conversely,  the  longer  the  period  of  follow-
p,  the  greater  the  probability  of  OSA  relapse.37 However,
a
s
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 more  recent  study38 has  shown  that  these  results  can  be
aintained  in  longer  term  follow-up.  The  author  concluded
hat  the  reduction  in  intra-abdominal  pressure  due  to  excess
eight  loss  following  surgery  leads  to  a  clinically  signiﬁcant
mprovement  in  blood  oxygenation,  resulting  in  favorable
ffects  on  the  cerebral  respiratory  center.39 Therefore,  the
esults  are  conﬂicting  but  the  majority  suggests  that  weight
oss  persists  in  short/medium  term  (1--2  years)  and  there
s  a higher  probability  of  OSA  relapse  after  that  period.
ore  prospective  studies  with  longer  time  of  follow-up  are
eeded.
The  efﬁcacy  of  the  different  types  of  bariatric  surgery  on
mproving  sleep  apnea  (AHI/AI/RDI  reduction)  is  represented
n  Fig.  1. The  results  obtained  with  intragastric  balloon
IB),  sleeve  gastrectomy  (SG)  and  gastric  bypass  (GBP)  must
e  interpreted  with  caution,  as  only  one  study  for  each
ne  of  these  techniques  was  considered.  The  intervention
ith  a  combined  malabsorptive  and  restrictive  mechanism,
oux-en-Y  gastric  bypass  (RYGB),  was  more  efﬁcacious  in
mproving  sleep  apnea  (higher  AHI/AI/RDI  reduction)  than
he  purely  restrictive  one,  laparoscopic  adjustable  gastric
anding  (LAGB),  which  simply  reduces  oral  intake.  These
ifferences  in  efﬁcacy  have  already  been  described  in  other
tudies37,39 and  can  potentially  be  explained  by  the  two  main
actors  that  contribute  to  the  improvement  in  OSA  follow-
ng  bariatric  surgery:  weight-dependent  effects  (decreased
echanical  force  on  the  cervical  region,  upper  airway  and
iaphragm)  and  weight-independent  metabolic  effects.39 It
s  possible  to  summarize  these  metabolic  effects  as  the
cronym  BRAVE:  bile  ﬂow  alteration,  restriction  of  gas-
ric  size,  anatomical  gut  rearrangement  and  altered  ﬂow
f  nutrients,  vagal  manipulation  and  enteric  gut  hormone
odulation.39 Another  recent  study40 stated  a  correlation
etween  obesity/sleep  apnea  and  systemic  inﬂammation.
urthermore,  malabsorptive  bariatric  techniques  reduce
everal  inﬂammatory  biomarkers  leading  to  a  protective
nti-inﬂammatory  state.40 The  most  signiﬁcant  and  well
orrelated  with  sleep  apnea  biomarker  has  been  shown
o  be  soluble  TNF- receptor  2.40 Moreover,  it  also  seems
hat  a  decline  in  central  adiposity  and  in  the  production
f  adipokines  that  act  on  the  central  nervous  system,  like
eptin,  may  lead  to  increased  neuromuscular  control  of  pha-
yngeal  diameter.37
Therefore,  it  makes  sense  that  the  studies  that  did  not
chieve  the  considered  AHI  criteria  for  a  successful  surgery
Dixon  et  al.,12 Feigel-Guiller  et  al.,31 Lettieri  et  al.17)  used
 purely  restrictive  technique  (LAGB).
These  reports,  however,  should  be  interpreted  with  cau-
ion,  as  there  are  some  limitations  that  must  be  considered.
he  different  time  of  follow-up  between  studies  is  one  of  the
ost  signiﬁcant  and  important  issues  to  take  into  account.
s  previously  stated,  the  positive  results  reported  in  studies
ith  shorter  durations,  may  be  inﬂuenced  by  the  simulta-
eous  short-term  behavioral  changes,  such  as  an  increase  in
xercise  and  a  healthy  diet.  On  the  other  hand,  these  same
horter  term  studies  could  have  had  the  potential  to  produce
 sustained  weight  loss  and  improvement/resolution  on  OSA
AHI/AI/RDI  reduction)  that  was  underestimated.  Another
mportant  matter  is  that  15  of  the  22  studies  that  were
ssessed  were  from  series  with  loss  to  follow-up  (Table  1)  of
everal  patients  after  surgery,  which  could  have  led  to  biases
s  the  patients  with  the  greatest  improvement/results  did
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not  drop  out,  occurring  the  opposite  to  the  other  group
of  patients.  Furthermore,  the  different  patient’s  preoper-
ative  mean  BMI  and  mean  AHI  considered  (Table  1)  makes
the  results  very  hard  to  compare  and  extrapolate  between
different  studies.  These  values  were  heterogeneous  in  the
severity  of  obesity,  as  well  as  in  the  presence  and  sever-
ity  of  OSA.  Moreover,  another  potential  bias  arises  from  the
heterogeneous  male  predominance  present  in  the  majority
of  the  analyzed  studies,  making  the  extrapolation  to  the
general  sleep  apnea  patients  less  accurate.
The  difference  in  the  study  designs  used  (Table  1)  makes
the  comparison  between  the  analyzed  studies  more  difﬁcult.
Moreover,  most  of  them  used  a  full  type  1  polysomnography
to  diagnose  sleep  apnea  but  only  half  of  them  used  the  ESS
questionnaire  to  evaluate  symptoms,  also  contributing  to  a
possible  bias  in  the  studies  comparison.
Finally,  generalization  of  the  results  to  the  entire  popu-
lation  of  patients  with  OSA  and  obesity  must  be  done  with
extreme  caution,  as  in  the  majority  of  these  studies  the
leading  medical  condition  was  obesity  and  not  sleep  apnea.
Thereby,  the  extrapolation  to  patients  whose  main  medical
condition  is  sleep  apnea  may  be  biased.
In  summary,  bariatric  surgery  has  a  signiﬁcant  effect  on
OSA,  leading  to  resolution  or  improvement,  in  the  majority
of  cases,  at  least  in  the  short/medium  term  (1--2  years).  The
combined  malabsorptive  and  restrictive  surgical  techniques,
such  as  RYGB,  seem  to  be  the  most  efﬁcacious  in  resolving
and  improving  sleep  apnea.  The  different  results  must  be
interpreted  with  caution  as  there  are  many  potential  biases
resulting  from  heterogeneous  inclusion  criteria,  duration
of  follow-up,  diagnostic  methodology  and  assessed  varia-
bles.  More  randomized,  controlled  trials  with  homogeneous
inclusion  criteria,  diagnostic  methodology  and  duration  of
follow-up  are  needed,  in  order  to  assertively  conﬁrm  the
advantageous  effects  of  bariatric  surgery  on  OSA.
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